Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
BMJ Open Gastroenterol. 2021 Jan;8(1). doi: 10.1136/bmjgast-2020-000492.
Oesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcomes of radical radiotherapy (RT) in an older population treating squamous cell carcinoma (SCC) oesophagus.
Patients over 65 years receiving RT for SCC oesophagus between 2013 and 2016 in the West of Scotland were identified. Kaplan-Meier and Cox-regression analysis were used to compare overall survival (OS) between patients treated with radical RT and radical CRT.
There were 83 patients over 65 years treated with either RT (n=21) or CRT (n=62). There was no significant difference in median OS between CRT versus RT (26.8 months vs 28.5 months, p=0.92). All patients receiving RT completed their treatment whereas 11% of CRT patients did not complete treatment.
Survival in this non-trial older patient group managed with CRT is comparable to that reported in previous trials. RT shows better than expected outcomes which may reflect developments in RT technique. This review supports RT as an alternative in older patients, unfit for concurrent treatment.
食管癌仍然是全球癌症死亡的常见原因。越来越多的肿瘤中心正在治疗老年人群,合并症可能使放化疗(CRT)的多模式治疗无法进行。我们回顾了在老年人群中治疗食管鳞癌(SCC)时根治性放疗(RT)的结果。
在苏格兰西部,2013 年至 2016 年间,确定了接受 RT 治疗 SCC 食管的 65 岁以上患者。使用 Kaplan-Meier 和 Cox 回归分析比较了接受根治性 RT 和根治性 CRT 治疗的患者的总生存率(OS)。
共有 83 名 65 岁以上的患者接受了 RT(n=21)或 CRT(n=62)治疗。CRT 与 RT 相比,中位 OS 无显著差异(26.8 个月 vs 28.5 个月,p=0.92)。所有接受 RT 的患者均完成了治疗,而 CRT 组有 11%的患者未完成治疗。
在接受 CRT 治疗的这组非试验老年患者中,生存情况与之前的试验报告相似。RT 的结果好于预期,这可能反映了 RT 技术的发展。本综述支持 RT 作为不适合同步治疗的老年患者的替代治疗方法。